Australian-New Zealand Clinical Trial: A Stem Cell Longitudinal Analysis to Research Interventions to Target Progression of Myeloproliferative Neoplasm (CLARITY)

Australia, Nov. 2 -- The Australian New Zealand Clinical Trials Registry (ANZCTR) received information related to the study titled ‘A Stem Cell Longitudinal Analysis to Research Interventions to Target Progression of Myeloproliferative Neoplasm (CLARITY)’. The following are the other relevant details related to the trial:

Trial ID: 392098

Submit Date: 7/2/26 13:16

Study Type: Observational

Intervention: CLARITY is a prospective, multicentre observational study designed to investigate the biological, molecular and genomic correlates of interferon (IFN) alpha therapy in patients with high molecular risk myeloproliferative neoplasms (MPNs). The study aims to identify biological factors associated with treatment response, resistance and pat...